Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
Conditions
Cervical Carcinoma · Human Papillomavirus Infection
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
Contact: Principal Investigator (Warner K. Huh)Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
Contact: Principal Investigator (Lisa C. Flowers)Louisiana State University, Lafayette, Louisiana, United States
Contact: Principal Investigator (Michael E. Hagensee)Louisiana State University Health Science Center, New Orleans, Louisiana, United States
Contact: Principal Investigator (Michael E. Hagensee)Minneapolis VA Medical Center, Minneapolis, Minnesota, United States
Contact: Principal Investigator (Elisheva Danan)University of New Mexico Cancer Center, Albuquerque, New Mexico, United States
Contact: Principal Investigator (Cosette M. Wheeler)Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States
Contact: Principal Investigator (Mark H. Einstein)Montefiore Medical Center-Weiler Hospital, The Bronx, New York, United States
Contact: Principal Investigator (Mark H. Einstein)UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Contact: Principal Investigator (Lisa Rahangdale)University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States
Contact: Principal Investigator (Leeya F. Pinder)University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Jacqueline A. Bohn)University of Oklahoma, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Jacqueline A. Bohn)University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Carmen Guerra)UPMC-Magee Womens Hospital, Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Harold C. Wiesenfeld)University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Harold C. Wiesenfeld)UT MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Elizabeth Y. Chiao)Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Deanna L. Kepka)West Virginia University Healthcare, Morgantown, West Virginia, United States
Contact: Principal Investigator (Krista S. Pfaendler)
Study leads
Vikrant V Sahasrabuddhe
Principal Investigator
National Cancer Institute Division of Cancer Prevention